Navigation Links
STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
Date:8/20/2008

STEMCELL Technologies' AggreWell™400 plate is a novel tool for standardizing the generation of uniform embryoid bodies.

Vancouver, British Columbia (PRWEB) August 20, 2008 -- http://www.stemcell.com [STEMCELL Technologies], a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, today announced the release of the AggreWell™400 plates, a revolutionary tool for researchers using embryonic and induced pluripotent stem cells (ESC and iPSC).

"The AggreWell™400 plate standardizes a critical step in the development of embryonic and induced pluripotent stem cells into clinically-relevant mature cells," says Clive Glover, Ph.D., STEMCELL Technologies' Product Manager for Pluripotent Stem Cell Biology. "These cells have been difficult to work with because of the lack of standardized methods to culture and differentiate them. The AggreWell™400 plate is the latest product in STEMCELL Technologies' portfolio that addresses the need for standardized methods and tools for stem cell research."

Many protocols for inducing the development ESC and iPSC into clinically relevant cell types rely on the formation of embryoid bodies (EBs), which are 3-dimensional aggregates of cells. In addition to being labor-intensive, current methods for making EBs results in aggregates that are inconsistent in size and shape, leading to inefficient differentiation.

In contrast, researchers using the AggreWell™400 plates are able to control the size of EBs, enabling them to optimize their differentiation protocols. Additionally the AggreWell™400 plates allow stem cell scientists to easily create large quantities of uniformly-sized EBs

For more information about the AggreWell™400 plates, visit www.stemcell.com/News_Info/aggrewell400_release.aspx.

Contact
Clive Glover, PhD, Product Manager- Pluripotent Stem Cell Biology
STEMCELL Technologies Inc
604 675 7723    
clive.glover(at)STEMCELL.com

About STEMCELL Technologies
STEMCELL Technologies, a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, is a privately-owned biotechnology company based in Vancouver, Canada. Driven by science, STEMCELL Technologies delivers over 800 products to more than 70 countries worldwide including mTeSR™1, a defined, feeder-independent medium for hESC and hiPSC. To learn more about how STEMCELL Technologies helps to make research work, visit www.stemcell.com.

###

Read the full story at http://www.prweb.com/releases/2008/08/prweb1229004.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
2. VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy
3. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
4. Frost & Sullivan Honors ConforMIS for Its Contribution to Personalized Care Through its Customized Implant Development Technologies
5. Wound Management Technologies, Inc. Announces Clarification of Eprint Viewing of Case Report in Advances in Skin and Wound Journal
6. IDE Technologies Signs Contract Worth Over 100 Million Euros to Supply a Desalination Plant to Australia
7. China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
8. Free White Paper: Hospital Tests Patient Lift Technologies; Improves Quality of Care
9. Wound Management Technologies, Inc. Announces Products to Be Registered in Taiwan
10. On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace
11. VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: